ARTICLE | Company News
Proteonomix Inc., University of Miami deal
December 5, 2011 8:00 AM UTC
Proteonomix and the university will conduct a clinical study to test UMK-121 in patients with end-stage liver disease. The university will pay expenses associated with the study and the company will ...